Modulation of Graft Arteriosclerosis in a Rat Carotid Transplantation Model

Journal of Surgical Research

Volumn 145, Issue 1, 2008, Pages 161-169

  Zdoroveac, Andrei ^a   Doebis, Cornelia ^a   Laube, Horst ^b   Brösel, Sabine ^a   Schmitt Knosalla, Isabela ^a   Volk, Hans Dieter ^a   Seifert, Martina ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

arteriosclerosis; carotid artery; gene therapy; Intrabody; MHC class I; transplantation

Indexed keywords

ADENOVIRUS VECTOR; ALLOANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOSCLEROSIS; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; GENE TRANSFER; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADENOVIRIDAE; ANIMALS; ANTIBODIES; ANTIGENS, CD3; ARTERIOSCLEROSIS; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE TRANSFER TECHNIQUES; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; MALE; RATS; RATS, INBRED LEW; RATS, INBRED WF; RNA, MESSENGER; TRANSPLANTATION IMMUNOLOGY;

EID: 39149096610     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.08.031     Document Type: Article

References (36)

1. Suma H., Isomura T., Horii T., et al. Isolated effect of partial left ventriculectomy for dilated cardiomyopathy: A case report. J Cardiol 33 (1999) 273
2. Moriyama S., Utoh J., Sun L.B., et al. Antigenicity of cryopreserved arterial allografts: Comparison with fresh and glutaraldehyde treated grafts. ASAIO J 47 (2001) 202
3. Libby P., and Pober J.S. Chronic rejection. Immunity 14 (2001) 387
4. Sata M., Luo Z., and Walsh K. Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia. J Immunol 166 (2001) 6964
5. Religa P., Bojakowski K., Bojakowska M., et al. Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis. Cardiovasc Res 65 (2005) 535
6. Hancock W.W., Shi C., Picard M.H., et al. LEW-to-F344 carotid artery allografts: Analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses. Transplantation 60 (1995) 1565
7. Denton M.D., Davis S.F., Baum M.A., et al. The role of the graft endothelium in transplant rejection: Evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection. Pediatr Transplant 4 (2000) 252
8. Lechler R.I., Lombardi G., Batchelor J.R., et al. The molecular basis of alloreactivity. Immunol Today 11 (1990) 83
9. Vella J.P., Vos L., Carpenter C.B., et al. Role of indirect allorecognition in experimental late acute rejection. Transplantation 64 (1997) 1823
10. Watschinger B., Gallon L., Carpenter C.B., et al. Mechanisms of allorecognition. Recognition by in vivo primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 57 (1994) 572
11. Valujskikh A., Lantz O., Celli S., et al. Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol 3 (2002) 844
12. Kapessidou Y., Habran C., Buonocore S., et al. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells. Transplantation 82 (2006) 582
13. Kreisel D., Krupnick A.S., Balsara K.R., et al. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J Immunol 169 (2002) 6154
14. Rothermel A.L., Wang Y., Schechner J., et al. Endothelial cells present antigens in vivo. BMC Immunol 5 (2004) 5
15. Mhashilkar A.M., Doebis C., Seifert M., et al. Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes. Gene Ther 9 (2002) 307
16. Doebis C., Schu S., Ladhoff J., et al. An anti-major histocompatibility complex class I intrabody protects endothelial cells from an attack by immune mediators. Cardiovasc Res 72 (2006) 331
17. Beyer F., Doebis C., Busch A., et al. Decline of surface MHC I by adenoviral gene transfer of anti-MHC I intrabodies in human endothelial cells-new perspectives for the generation of universal donor cells for tissue transplantation. J Gene Med 6 (2004) 616
18. Kolls J., Peppel K., Silva M., et al. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA 91 (1994) 215
19. Nicosia R.F., Villaschi S., and Smith M. Isolation and characterization of vasoformative endothelial cells from the rat aorta. In Vitro Cell Dev Biol Anim 30A (1994) 394
20. Zhang L., Moskovitz M., Baron D.A., et al. Different types of sleeve anastomosis. J Reconstr Microsurg 11 (1995) 461
21. McWhinnie D.L., Thompson J.F., Taylor H.M., et al. Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation 42 (1986) 352
22. Chauveau C., Bouchet D., Roussel J.C., et al. Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2 (2002) 581
23. Kotsch K., Mashreghi M.F., Bold G., et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 77 (2004) 1866
24. Laitinen M., Pakkanen T., Donetti E., et al. Gene transfer into the carotid artery using an adventitial collar: Comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses. Hum Gene Ther 8 (1997) 1645
25. Gruchala M., Bhardwaj S., Pajusola K., et al. Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors. J Gene Med 6 (2004) 545
26. Boldicke T. Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER. J Cell Mol Med 11 (2007) 54
27. Isik F.F., McDonald T.O., Ferguson M., et al. Transplant arteriosclerosis in a rat aortic model. Am J Pathol 141 (1992) 1139
28. Ross R. Genetically modified mice as models of transplant atherosclerosis. Nat Med 2 (1996) 527
29. Ensminger S.M., Spriewald B.M., Witzke O., et al. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts. Transplantation 73 (2002) 1068
30. Muruve D.A. The innate immune response to adenovirus vectors. Hum Gene Ther 15 (2004) 1157
31. Tellides G., Tereb D.A., Kirkiles-Smith N.C., et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 403 (2000) 207
32. Nagano H., Mitchell R.N., Taylor M.K., et al. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 100 (1997) 550
33. Weis M., and von Scheidt W. Cardiac allograft vasculopathy: A review. Circulation 96 (1997) 2069
34. Wu G.D., Jin Y.S., Salazar R., et al. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: A possible injury pathway contributing to chronic allograft rejection. J Heart Lung Transplant 21 (2002) 1174
35. Jin Y.P., Jindra P.T., Gong K.W., et al. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation 79 (2005) S19
36. Naji A., Deschaseaux F., Racadot E., et al. Induction of tissue factor expression on human umbilical vein endothelial cells by cell-specific HLA class I antibody: Preliminary data. Transplant Proc 37 (2005) 2892